Naoero vs Panama: Drug use disorder death rate
Naoero
0.16 deaths per 100,000 people
in 2021
Panama
0.16 deaths per 100,000 people
in 2021
Naoero rank
139th
Panama rank
139th
Drug use disorder death rate over time
- Naoero
- Panama
How they compare
Naoero currently reports 0.16 deaths per 100,000 people against 0.16 deaths per 100,000 people in Panama, a difference of 0 deaths per 100,000 people.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Panama ahead.
Naoero ranks 139th and Panama ranks 139th of 194 countries.
Panama has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Naoero | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.192 deaths per 100,000 people | 0.293 deaths per 100,000 people | 0.101 deaths per 100,000 people | Panama |
| 2010s | 0.155 deaths per 100,000 people | 0.211 deaths per 100,000 people | 0.056 deaths per 100,000 people | Panama |
| 2020s | 0.16 deaths per 100,000 people | 0.205 deaths per 100,000 people | 0.045 deaths per 100,000 people | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher drug use disorder death rate, Naoero or Panama?
- Naoero, at 0.16 deaths per 100,000 people against 0.16 deaths per 100,000 people in Panama as of 2021.
- What is the difference in drug use disorder death rate between Naoero and Panama?
- 0 deaths per 100,000 people, with Naoero ahead.
- How many years of comparable data are there for Naoero and Panama?
- 22 years are reported by both, from 2000 to 2021.
- How do Naoero and Panama rank globally for drug use disorder death rate?
- Naoero ranks 139th and Panama ranks 139th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Drug use disorder death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from drug use disorders in both sexes, per 100,000 people.